AxoGen's market cap is currently $789.95M. The company's EPS TTM is $-0.33; its P/E ratio is ―; AxoGen is scheduled to report earnings on March 4, 2025, and the estimated EPS forecast is $0.04. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 159.01M	$ 138.58M	$ 127.36M	$ 112.30M	$ 106.71M
Gross Profit	$ 127.87M	$ 114.44M	$ 104.43M	$ 90.72M	$ 89.36M
Operating Income	$ -21.46M	$ -29.71M	$ -25.42M	$ -23.18M	$ -31.41M
EBITDA	$ -13.33M	$ -23.47M	$ -20.89M	$ -19.27M	$ -26.22M
Net Income	$ -21.72M	$ -27.34M	$ -28.06M	$ -24.80M	$ -29.12M
Balance Sheet
Cash & Short-Term Investments	$ 31.02M	$ 48.79M	$ 84.09M	$ 103.97M	$ 96.51M
Total Assets	$ 196.83M	$ 195.39M	$ 208.02M	$ 201.38M	$ 154.64M
Total Debt	$ 69.29M	$ 67.43M	$ 67.45M	$ 53.76M	$ 3.33M
Net Debt	$ 38.27M	$ 52.14M	$ 34.70M	$ 5.00M	$ -32.39M
Total Liabilities	$ 101.16M	$ 94.39M	$ 95.47M	$ 78.23M	$ 22.49M
Stockholders' Equity	$ 95.67M	$ 101.00M	$ 112.55M	$ 123.15M	$ 132.15M
Cash Flow
Free Cash Flow	$ -20.63M	$ -37.32M	$ -41.80M	$ -32.22M	$ -141.51M
Operating Cash Flow	$ -5.72M	$ -16.07M	$ -13.40M	$ -9.63M	$ -19.87M
Investing Cash Flow	$ 19.25M	$ -3.20M	$ -23.65M	$ -16.96M	$ 27.27M
Financing Cash Flow	$ 1.95M	$ 1.79M	$ 20.45M	$ 40.47M	$ 4.03M

Currency in USD

AxoGen Earnings and Revenue History

Income Statement >

AxoGen Debt to Assets

Balance Sheet >

AxoGen Cash Flow

Cash Flow >

AxoGen Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing